Contributions of Glucose and Hemoglobin A1c Measurements in Diabetes Screening.
Lee H HilborneCaixia BiJeff RadcliffMartin H KrollHarvey W KaufmanPublished in: American journal of clinical pathology (2021)
Although many health plans do not cover HbA1c testing for diabetes screening, more than 1 in 4 glucose screening patients 60 years of age or older with an in-range glucose result had a concurrent elevated HbA1c result. Guideline developers and health plans should explicitly recognize that glucose and HbA1c provide complementary information and together offer improved clinical utility for diabetes screening.
Keyphrases
- type diabetes
- blood glucose
- cardiovascular disease
- glycemic control
- healthcare
- public health
- health information
- ejection fraction
- newly diagnosed
- end stage renal disease
- squamous cell carcinoma
- health insurance
- physical activity
- metabolic syndrome
- prognostic factors
- blood pressure
- locally advanced
- patient reported
- red blood cell